Scientists and trainees from Yale Cancer Center attended the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, held May 30–June 3, to showcase groundbreaking research from Yale Cancer Center and Smilow Cancer Hospital. The largest and most influential gathering of oncology professionals in the world, the ASCO meeting fosters critical connections and collaborations that shape the future of cancer care.
Yale Cancer Center Researchers and Trainees Present at 2025 ASCO Annual Meeting
Yale research shared through 50 presentations at the Annual Society of Clinical Oncology annual meeting in Chicago
ASCO 2025
Dr. Patricia LoRusso presents Dr. Patricia LoRusso Dr. Philippos Costa and Irvin Yi present on "Treatment discontinuation in desmoid tumors: Factors associated with better outcomes after sorafenib discontinuation" ASCO Awards - Dr. Ian Krop Dr. Ian Krop ASCO award recipient Dr. Patricia LoRusso presents Dr. Patricia LoRusso Dr. Philippos Costa and Irvin Yi present on "Treatment discontinuation in desmoid tumors: Factors associated with better outcomes after sorafenib discontinuation" ASCO Awards - Dr. Ian Krop Dr. Ian Krop ASCO award recipient Dr. Patricia LoRusso presents Dr. Patricia LoRusso Dr. Philippos Costa and Irvin Yi present on "Treatment discontinuation in desmoid tumors: Factors associated with better outcomes after sorafenib discontinuation" ASCO Awards - Dr. Ian Krop Dr. Ian Krop ASCO award recipient
This year’s meeting, themed Driving Knowledge to Action: Building a Better Futin, featured more than 200 sessions. Yale Cancer Center contributed 50 oral, educational, and poster presentations, highlighting significant advances in cancer treatment and care driven by clinical trials and translational research from Smilow Cancer Hospital.
ASCO 2025
2025 Conquer Cancer Award Recipients Conquer Cancer Award Celebration Conquer Cancer Award Celebration Dr. Luisa Ladel presents a poster on "Identification of differential epigenetic landscapes in subtypes of appendiceal cancer" Irvin Yi and Dr. David Schoenfeld during the trainee poster session 2025 Conquer Cancer Award Recipients Conquer Cancer Award Celebration Conquer Cancer Award Celebration Dr. Luisa Ladel presents a poster on "Identification of differential epigenetic landscapes in subtypes of appendiceal cancer" Irvin Yi and Dr. David Schoenfeld during the trainee poster session 2025 Conquer Cancer Award Recipients Conquer Cancer Award Celebration Conquer Cancer Award Celebration Dr. Luisa Ladel presents a poster on "Identification of differential epigenetic landscapes in subtypes of appendiceal cancer" Irvin Yi and Dr. David Schoenfeld during the trainee poster session
During the meeting, five trainees were honored by the Conquer Cancer Foundation with awards, including Young Investigator Award recipients Devora Isseroff, MD, and Amin Nassar, MD; Merit Award recipients Rebecca Forman, MD, and Faiza Yasin, MD, and Nicole Casasanta, MD, recipient of the Gianni Bonadonna Breast Cancer Research Fellowship. In addition, Benjamin Lu, MD, and Mariya Rozenblit, MD, received prestigious Career Development Awards.
ASCO 2025
Dr. Barbara Burtness Dr. Michael Cecchini and Dr. Faiza Yasin present on "Comparison of MET genomic alterations (GA) identified in colorectal cancer (CRC) vs gastric cancer (GCA)" Dr. Tendai Kwaramba presents "Risk and predictors of late second primary malignancies in long-term breast, prostate, colon, and rectal cancer survivors" Dr. David Braun presents on "An integrative analysis of circulating and tumor microenvironment (TME) determinants of patient response in the Checkmate 9ER (CM 9ER) trial of nivolumab and cabozantinib (NIVO+CABO) in advanced renal cell carcinoma (aRCC)" Drs. Cary Gross and Jacquelyne Gaddy present "The impact of race on the association between structural racism and the quality of non-small cell lung cancer (NSCLC)" Dr. Barbara Burtness Dr. Michael Cecchini and Dr. Faiza Yasin present on "Comparison of MET genomic alterations (GA) identified in colorectal cancer (CRC) vs gastric cancer (GCA)" Dr. Tendai Kwaramba presents "Risk and predictors of late second primary malignancies in long-term breast, prostate, colon, and rectal cancer survivors" Dr. David Braun presents on "An integrative analysis of circulating and tumor microenvironment (TME) determinants of patient response in the Checkmate 9ER (CM 9ER) trial of nivolumab and cabozantinib (NIVO+CABO) in advanced renal cell carcinoma (aRCC)" Drs. Cary Gross and Jacquelyne Gaddy present "The impact of race on the association between structural racism and the quality of non-small cell lung cancer (NSCLC)" Dr. Barbara Burtness Dr. Michael Cecchini and Dr. Faiza Yasin present on "Comparison of MET genomic alterations (GA) identified in colorectal cancer (CRC) vs gastric cancer (GCA)" Dr. Tendai Kwaramba presents "Risk and predictors of late second primary malignancies in long-term breast, prostate, colon, and rectal cancer survivors" Dr. David Braun presents on "An integrative analysis of circulating and tumor microenvironment (TME) determinants of patient response in the Checkmate 9ER (CM 9ER) trial of nivolumab and cabozantinib (NIVO+CABO) in advanced renal cell carcinoma (aRCC)" Drs. Cary Gross and Jacquelyne Gaddy present "The impact of race on the association between structural racism and the quality of non-small cell lung cancer (NSCLC)"
Ian E. Krop, MD, PhD, was honored with the prestigious Gianni Bonadonna Breast Cancer Award, introduced by close friend and colleague Eric Winer, MD.
ASCO 2025
Fellows supporting Dr. Curt Perry at his oral presentation Dr. Jing Du presents "Quantifying the clinical impact of tissue reflex testing for liquid biopsy ESR1 mutation–negative cases with low ctDNA tumor fraction (TF) in HR(+)HER2(-) breast cancer" Dr. Tara Sanft presents on a "Prospective decision impact study of the Breast Cancer Index: Results from the BCI Registry study" Ismail Ajjawi presents on "Clinical, sociodemographic, and facility-related determinants of immunotherapy use in metastatic triple-negative breast cancer" Drs. Tom Lynch and Eric Winer Fellows supporting Dr. Curt Perry at his oral presentation Dr. Jing Du presents "Quantifying the clinical impact of tissue reflex testing for liquid biopsy ESR1 mutation–negative cases with low ctDNA tumor fraction (TF) in HR(+)HER2(-) breast cancer" Dr. Tara Sanft presents on a "Prospective decision impact study of the Breast Cancer Index: Results from the BCI Registry study" Ismail Ajjawi presents on "Clinical, sociodemographic, and facility-related determinants of immunotherapy use in metastatic triple-negative breast cancer" Drs. Tom Lynch and Eric Winer Fellows supporting Dr. Curt Perry at his oral presentation Dr. Jing Du presents "Quantifying the clinical impact of tissue reflex testing for liquid biopsy ESR1 mutation–negative cases with low ctDNA tumor fraction (TF) in HR(+)HER2(-) breast cancer" Dr. Tara Sanft presents on a "Prospective decision impact study of the Breast Cancer Index: Results from the BCI Registry study" Ismail Ajjawi presents on "Clinical, sociodemographic, and facility-related determinants of immunotherapy use in metastatic triple-negative breast cancer" Drs. Tom Lynch and Eric Winer
To relax and reconnect, Yale Cancer Center hosted a reception on Sunday evening for current and former oncology faculty and trainees. The event, hosted by Eric Winer, MD, and Roy Herbst, MD, PhD, offered a welcome break from the fast pace of the ASCO meeting.
ASCO 2025
Dr. Dan Petrylak, Dr. Lajos Pusztai, and guest Drs. William Oh, Mario Sznol, and Debbie Doroshow Dr. Debbie Doroshow and Dr. Amer Zeidan Scott Capozza and Dr. Kevin Billingsley Dr. Roy Herbst, Laura Pappano, Dr. Navid Hafez, and Dr. Tom Lynch Dr. Dan Petrylak, Dr. Lajos Pusztai, and guest Drs. William Oh, Mario Sznol, and Debbie Doroshow Dr. Debbie Doroshow and Dr. Amer Zeidan Scott Capozza and Dr. Kevin Billingsley Dr. Roy Herbst, Laura Pappano, Dr. Navid Hafez, and Dr. Tom Lynch Dr. Dan Petrylak, Dr. Lajos Pusztai, and guest Drs. William Oh, Mario Sznol, and Debbie Doroshow Dr. Debbie Doroshow and Dr. Amer Zeidan Scott Capozza and Dr. Kevin Billingsley Dr. Roy Herbst, Laura Pappano, Dr. Navid Hafez, and Dr. Tom Lynch
ASCO 2026 will take place May 29 - June 2, 2026 in Chicago.
ASCO 2025
Drs. Kert Sabbath, Jeremy Kortmansky, Sarah Goldberg, Pam Kunz, and Eric Winer Dr. Rogerio Lilenbaum and Dr. Harriet Kluger Dr. Michael Cecchini and Dr. Ranjit Bindra Renee Saliby, Dr. David Brain, and Joy Byrne Our GI team Drs. Kert Sabbath, Jeremy Kortmansky, Sarah Goldberg, Pam Kunz, and Eric Winer Dr. Rogerio Lilenbaum and Dr. Harriet Kluger Dr. Michael Cecchini and Dr. Ranjit Bindra Renee Saliby, Dr. David Brain, and Joy Byrne Our GI team Drs. Kert Sabbath, Jeremy Kortmansky, Sarah Goldberg, Pam Kunz, and Eric Winer Dr. Rogerio Lilenbaum and Dr. Harriet Kluger Dr. Michael Cecchini and Dr. Ranjit Bindra Renee Saliby, Dr. David Brain, and Joy Byrne Our GI team
Article outro
Tags
Media Contact
Explore More
Copy Link
Featured in this article
- Ismail Ajjawi
- Elizabeth Berger, MD, MS, FACSAssistant Professor of Surgery (Oncology, Breast)
- Aarti Bhatia, MD, MPHAssociate Professor of Medicine (Medical Oncology)
- Kevin Billingsley, MD, MBA, FACSProfessor of Surgery (Oncology)
- Ranjit S. Bindra, MD, PhDHarvey and Kate Cushing Professor of Therapeutic Radiology and Professor of Pathology
- David A. Braun, MD, PhDAssistant Professor of Medicine (Medical Oncology), Louis Goodman and Alfred Gilman Yale Scholar
- Barbara Burtness, MDAnthony N. Brady Professor of Medicine (Medical Oncology)
- Nicole Casasanta, MDClinical Fellow
- Michael Cecchini, MDAssociate Professor of Medicine (Medical Oncology)
- Anne Chiang, MD, PhDAssociate Professor
- Philippos Costa, MDAssistant Professor of Medicine (Medical Oncology and Hematology)
- Jing Du, MD, PhDAssistant Professor of Medicine (Medical Oncology/Hematology)
- Jacquelyne Gaddy, MD, MSc, MSCRAssistant Professor
- Sarah Goldberg, MD, MPHProfessor of Internal Medicine (Medical Oncology & Hematology)
- Cary P Gross, MDProfessor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases)
- Roy S. Herbst, MD, PhDEnsign Professor of Medicine (Medical Oncology) and Professor of Pharmacology
- Adriana Kahn, MDAssistant Professor of Medicine (Medical Oncology)
- So Yeon Kim, MDAssistant Professor
- Harriet Kluger, MDHarvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology
- Jeremy Kortmansky, MDAssociate Professor of Medicine (Medical Oncology)
- Ian Krop, MD, PhDProfessor of Internal Medicine (Medical Oncology)
- Pamela L. Kunz, MDProfessor of Internal Medicine (Medical Oncology)
- Luisa LadelHospital Resident
- Jonathan Leventhal, MDAssociate Professor Term
- Patricia LoRusso, DOAmy and Joseph Perella Professor of Medicine (Medical Oncology)
- Maryam Lustberg, MD, MPHProfessor of Internal Medicine (Medical Oncology)
- Meena S. Moran, MDProfessor of Therapeutic Radiology
- Yunan Nie, MDClinical Fellow
- William K. Oh, MDProfessor of Internal Medicine (Medical Oncology & Hematology)
- Daniel O'Neil, MD, MPHAssistant Professor
- Curtis Jamison Perry, MD, PhDInstructor of Medicine (Medical Oncology & Hematology)
- Daniel P. Petrylak, MDProfessor of Medicine (Medical Oncology) and of Urology
- Kert Sabbath, MD, FACPAssociate Professor of Medicine (Medical Oncology)
- Renee Maria SalibyHospital Resident
- Tara Sanft, MDAssociate Professor of Medicine (Medical Oncology)
- Mario Sznol, MDProfessor of Medicine (Medical Oncology)
- Eric Winer, MDAlfred Gilman Professor of Pharmacology and Professor of Medicine (Medical Oncology)
- Amer Zeidan, MBBSProfessor of Internal Medicine (Hematology)